< Retour

ENTERAMIO: Pediatric formulation of amiodarone

SATT NORD

02 Mai 2016

Partager sur facebook

Partager sur twitter

Partager sur linkedin

Partager sur google+

Fields

Biology / Medical

Sectors

Health

New formulation of amiodarone adapted to pediatrics for the treatment of supraventricular tachycardia

Benefits:

Liquid formulation for oral administration
Easy to adapt the dosage
Opportunity to benefit from incentive measures for the development of pediatric products (PUMA)

Download the offer